immncorp1801
Primary Menu
About Us
Technology
Pipeline
Patients
News hub
News
Events
Careers
Menu
About Us
Technology
Pipeline
Patients
News hub
Careers
News
Archive / 2018
19 November 2018
Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech
26 October 2018
Immunocore CEO Andrew Hotchkiss appointed to the Board of the BIA
5 September 2018
Immunocore strengthens IP position in the field of TCR-based therapeutics
20 August 2018
Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours
16 July 2018
Immunocore Announces Management Change
4 June 2018
Immunocore Presents New IMCgp100-102 Data that Show Durable Response and Robust Overall Survival Rate in Patients with Metastatic Uveal Melanoma
22 May 2018
Immunocore to Present New Data from IMCgp100-102 Trial in Metastatic Uveal Melanoma at 2018 ASCO Annual Meeting
21 May 2018
Immunocore wins Large Business of the Year at the 2018 Vale4Business Awards
8 February 2018
Immunocore Announces Leadership Change
4 January 2018
Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors
Sign-up to receive news email alerts
Email address
Send
Please enter a valid email address
Thankyou. You have successfully subscribed to news updates.
News archive
Show all
2019 (3)
2018 (10)
2017 (13)
2016 (11)
2015 (20)
2014 (6)
2013 (11)
2012 (3)
2011 (1)
2010 (4)
2009 (1)
2008 (1)
